Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.95% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.98% |
| 4 | Financials | 6.14% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
X
2526
PUT
DELISTED
US Steel
X
| $5.15M | ﹤0.01% |
197,400
-400
| -0.2% | -$11.1K |
|
2527
BridgeBio Pharma
BBIO
$15B
| $5.15M | ﹤0.01% |
310,569
+226,392
| +269% | +$2.64M |
|
|
BLUE
2528
DELISTED
bluebird bio
BLUE
| $5.15M | ﹤0.01% |
80,958
+44,804
| +124% | +$5.12M |
|
2529
CALL
Rio Tinto
RIO
$168B
| $5.14M | ﹤0.01% |
+75,000
| New | +$5.44M |
|
2530
Clean Energy Fuels
CLNE
$359M
| $5.14M | ﹤0.01% |
1,179,801
+1,148,793
| +3,705% | +$5.93M |
|
2531
Harrow
HROW
$1.4B
| $5.14M | ﹤0.01% |
243,067
+91,564
| +60% | +$1.56M |
|
2532
Quaker Houghton
KWR
$2.85B
| $5.14M | ﹤0.01% |
25,955
+21,915
| +542% | +$4.19M |
|
2533
Warrior Met Coal
HCC
$5.65B
| $5.14M | ﹤0.01% |
139,930
-287,447
| -67% | -$10.6M |
|
|
FWAC
2534
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
| $5.13M | ﹤0.01% |
502,416
-858,335
| -63% | -$8.69M |
|
|
TGAA
2535
DELISTED
Target Global Acquisition I Corp. Class A Ordinary Share
TGAA
| $5.13M | ﹤0.01% |
491,500
-540,003
| -52% | -$5.59M |
|
2536
CALL
Fox Class A
FOXA
$28.8B
| $5.12M | ﹤0.01% |
+150,400
| New | +$5.08M |
|
2537
DocGo
DCGO
$39.3M
| $5.12M | ﹤0.01% |
591,571
+476,274
| +413% | +$4.2M |
|
|
DEVS
2538
DELISTED
DevvStream Corp
DEVS
| $5.1M | ﹤0.01% |
49,000
-9,067
| -16% | -$934K |
|
2539
CALL
Regeneron Pharmaceuticals
REGN
$81.8B
| $5.09M | ﹤0.01% |
6,200
-27,500
| -82% | -$20.7M |
|
|
XYZ
2540
CALL
Block Inc
XYZ
$50.2B
| $5.09M | ﹤0.01% |
74,200
-127,600
| -63% | -$9.55M |
|
2541
Cadre Holdings
CDRE
$1.32B
| $5.09M | ﹤0.01% |
236,190
-42,406
| -15% | -$917K |
|
|
CRON
2542
Cronos Group
CRON
$1.25B
| $5.08M | ﹤0.01% |
2,620,214
+804,957
| +44% | +$1.81M |
|
2543
CALL
Edison International
EIX
$27B
| $5.08M | ﹤0.01% |
72,000
+26,500
| +58% | +$1.79M |
|
2544
Motorcar Parts of America
MPAA
$218M
| $5.07M | ﹤0.01% |
+681,087
| New | +$8.11M |
|
2545
AdaptHealth
AHCO
$772M
| $5.04M | ﹤0.01% |
405,498
-380,633
| -48% | -$7M |
|
2546
Arbutus Biopharma
ABUS
$1B
| $5.03M | ﹤0.01% |
1,660,566
-192,149
| -10% | -$542K |
|
2547
Zeta Global
ZETA
$7.67B
| $5.02M | ﹤0.01% |
463,543
-713,141
| -61% | -$6.87M |
|
2548
PUT
Lucid Motors
LCID
$1.97B
| $5.01M | ﹤0.01% |
62,330
+57,270
| +1,132% | +$5.09M |
|
2549
PUT
Range Resources
RRC
$9.69B
| $5M | ﹤0.01% |
188,700
+93,300
| +98% | +$2.35M |
|
2550
Vanguard Dividend Appreciation ETF
VIG
$113B
| $4.98M | ﹤0.01% |
+32,327
| New | +$4.95M |
|
Similar funds
Israel Englander's Q1 2023 Portfolio in Review
As of Q1 2023, Israel Englander held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Israel Englander withdrew a net $7.42B in Q1 2023, closing 1,206 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Israel Englander opened a new position in Warner Bros worth $96.9M.
- Israel Englander's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Israel Englander added most to Linde in Q1 2023, an estimated $374M increase.
- Israel Englander's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Israel Englander fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Israel Englander's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Israel Englander opened 987 new positions and closed 1,206 in Q1 2023.
- Israel Englander's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.